|
1
|
Greenstein S, Krett NL, Kurosawa Y, Ma C,
Chauhan D, Hideshima T, Anderson KC and Rosen ST: Characterization
of the MM.1 human multiple myeloma (MM) cell lines: A model system
to elucidate the characteristics, behavior, and signaling of
steroid-sensitive and -resistant MM cells. Exp Hematol. 31:271–282.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Becker N: Epidemiology of multiple
myeloma. Multiple myeloma. Springer; Berlin, Heidelberg: pp.
1832011
|
|
3
|
Rajkumar SV and Kumar S: Multiple myeloma:
Diagnosis and treatment. Mayo Clin Proc. 91:101–119. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Combination chemotherapy versus melphalan
plus prednisone as treatment for multiple myeloma: An overview of
6,633 patients from 27 randomized trials. Myeloma Trialists'
Collaborative Group. J Clin Oncol. 16:3832–3842. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kyle RA, Gertz MA, Witzig TE, Lust JA,
Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson
DR, et al: Review of 1,027 patients with newly diagnosed multiple
myeloma. Mayo Clin Proc. 78:21–33. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giuliani N, Colla S and Rizzoli V: New
insight in the mechanism of osteoclast activation and formation in
multiple myeloma: Focus on the receptor activator of NF-kappaB
ligand (RANKL). Exp Hematol. 32:685–691. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Magrangeas F, Cormier ML, Descamps G, Gouy
N, Lodé L, Mellerin MP, Harousseau JL, Bataille R, Minvielle S and
Avet-Loiseau H: Light-chain only multiple myeloma is due to the
absence of functional (productive) rearrangement of the IgH gene at
the DNA level. Blood. 103:3869–3875. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bakkus MH, Heirman C, Van Riet I, Van Camp
B and Thielemans K: Evidence that multiple myeloma Ig heavy chain
VDJ genes contain somatic mutations but show no intraclonal
variation. Blood. 80:2326–2335. 1992.PubMed/NCBI
|
|
9
|
Nishida K, Tamura A, Nakazawa N, Ueda Y,
Abe T, Matsuda F, Kashima K and Taniwaki M: The Ig heavy chain gene
is frequently involved in chromosomal translocations in multiple
myeloma and plasma cell leukemia as detected by in situ
hybridization. Blood. 90:526–534. 1997.PubMed/NCBI
|
|
10
|
Gygi SP, Rochon Y, Franza BR and Aebersold
R: Correlation between protein and mRNA abundance in yeast. Mol
Cell Biol. 19:1720–1730. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lian Z, Wang L, Yamaga S, Bonds W,
Beazer-Barclay Y, Kluger Y, Gerstein M, Newburger PE, Berliner N
and Weissman SM: Genomic and proteomic analysis of the myeloid
differentiation program. Blood. 98:513–524. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ota J, Yamashita Y, Okawa K, Kisanuki H,
Fujiwara S, Ishikawa M, Lim Choi Y, Ueno S, Ohki R, Koinuma K, et
al: Proteomic analysis of hematopoietic stem cell-like fractions in
leukemic disorders. Oncogene. 22:5720–5728. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang HT, Tian EB, Chen YL, Deng HT and
Wang QT: Proteomic analysis for finding serum pathogenic factors
and potential biomarkers in multiple myeloma. Chin Med J (Engl).
128:1108–1113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dowling P, Hayes C, Ting KR, Hameed A,
Meiller J, Mitsiades C, Anderson KC, Clynes M, Clarke C, Richardson
P and O'Gorman P: Identification of proteins found to be
significantly altered when comparing the serum proteome from
multiple Myeloma patients with varying degrees of bone disease. BMC
Genomics. 15:9042014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hanash SM, Bobek MP, Rickman DS, Williams
T, Rouillard JM, Kuick R and Puravs E: Integrating cancer genomics
and proteomics in the post-genome era. Proteomics. 2:69–75. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chance MR, Chang J, Schlatzer D and Miyagi
M: Quantitative proteomics. Encyclopedia of analytical chemistry:
Applications, theory and instrumentation. Meyers RA: John Wiley
& Sons, Ltd; pp. 1–23. 2009
|
|
17
|
Scheler C, Lamer S, Pan Z, Li XP, Salnikow
J and Jungblut P: Peptide mass fingerprint sequence coverage from
differently stained proteins on two-dimensional electrophoresis
patterns by matrix assisted laser desorption/ionization-mass
spectrometry (MALDI-MS). Electrophoresis. 19:918–927. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hellman U, Wernstedt C, Góñez J and Heldin
CH: Improvement of an ‘In-Gel’ digestion procedure for the
micropreparation of internal protein fragments for amino acid
sequencing. Anal Biochem. 224:451–455. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shevchenko A, Wilm M, Vorm O and Mann M:
Mass spectrometric sequencing of proteins silver-stained
polyacrylamide gels. Anal Chem. 68:850–858. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kwak JY, Ma TZ, Yoo MJ, Choi BH, Kim HG,
Kim SR, Yim CY and Kwak YG: The comparative analysis of serum
proteomes for the discovery of biomarkers for acute myeloid
leukemia. Exp Hematol. 32:836–842. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Clauser KR, Baker P and Burlingame AL:
Role of accurate mass measurement (+/-10 ppm) in protein
identification strategies employing MS or MS/MS and database
searching. Anal Chem. 71:2871–2882. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang SB, Chen F, Sommerfeld M and Hu Q:
Proteomic analysis of molecular response to oxidative stress by the
green alga Haematococcus pluvialis (Chlorophyceae). Planta.
220:17–29. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhengfei D, Longping L, Xinghua W, et al:
Measurement of serum levels of β2-microglobulin and
high-sensitivity C-reactive protein in multiple myeloma and their
clinical significances. China Healthcare Innovat. 6:0692008.
|
|
25
|
Kyrtsonis MC, Vassilakopoulos TP, Kafasi
N, Sachanas S, Tzenou T, Papadogiannis A, Galanis Z, Kalpadakis C,
Dimou M, Kyriakou E, et al: Prognostic value of serum free light
chain ratio at diagnosis in multiple myeloma. Br J Haematol.
137:240–243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barnidge DR, Tschumper RC, Theis JD,
Snyder MR, Jelinek DF, Katzmann JA, Dispenzieri A and Murray DL:
Monitoring M-proteins in patients with multiple myeloma using
heavy-chain variable region clonotypic peptides and LC-MS/MS. J
Proteome Res. 13:1905–1910. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan F, Egile C, Lipkin T and Li R:
ARPC1/Arc40 mediates the interaction of the actin-related protein 2
and 3 complex with Wiskott-Aldrich syndrome protein family
activators. J Biol Chem. 279:54629–54636. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kahr WH, Pluthero FG, Elkadri A, Warner N,
Drobac M, Chen CH, Lo RW, Li L, Li R, Li Q, et al: Loss of the
Arp2/3 complex component ARPC1B causes platelet abnormalities and
predisposes to inflammatory disease. Nat Commun. 8:148162017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Malinova D, Fritzsche M, Nowosad CR, Armer
H, Munro PM, Blundell MP, Charras G, Tolar P, Bouma G and Thrasher
AJ: WASp-dependent actin cytoskeleton stability at the dendritic
cell immunological synapse is required for extensive, functional T
cell contacts. J Leukoc Biol. 99:699–710. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Avet-Loiseau H, Brigaudeau C, Morineau N,
Talmant P, Laï JL, Daviet A, Li JY, Praloran V, Rapp MJ, Harousseau
JL, et al: High incidence of cryptic translocations involving the
Ig heavy chain gene in multiple myeloma, as shown by fluorescence
in situ hybridization. Genes Chromosomes Cancer. 24:9–15. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Szczepek AJ, Seeberger K, Wizniak J, Mant
MJ, Belch AR and Pilarski LM: A high frequency of circulating B
cells share clonotypic Ig heavy-chain VDJ rearrangements with
autologous bone marrow plasma cells in multiple myeloma, as
measured by single-cell and in situ reverse
transcriptase-polymerase chain reaction. Blood. 92:2844–2855.
1998.PubMed/NCBI
|
|
32
|
Jo JC, Yoon DH, Kim S, Lee K, Kang EH,
Jang S, Park CJ, Chi HS, Huh J, Park CS and Suh C: Clinical
significance of the appearance of abnormal protein band in patients
with multiple myeloma. Ann Hematol. 93:463–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Frick PG: Inhibition of conversion of
fibrinogen to fibrin by abnormal proteins in multiple myeloma. Am J
Clin Pathol. 25:1263–1273. 1955. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lopaciuk S, Snigurowicz J, Rostkowska J,
Pniejnia-Olszynski W and Powiertowska-Rezmer M: Disorders in the
conversion of fibrinogen to fibrin in patients with multiple
myeloma. Acta Haematol Pol. 9:157–164. 1978.(In Polish). PubMed/NCBI
|
|
35
|
Lominadze D, Tsakadze N, Sen U, Falcone JC
and D'Souza SE: Fibrinogen and fragment D-induced vascular
constriction. Am J Physiol Heart Circ Physiol. 288:H1257–H1264.
2015. View Article : Google Scholar
|
|
36
|
Miller J, McLachlan AD and Klug A:
Repetitive zinc-binding domains in the protein transcription factor
IIIA from Xenopus oocytes. EMBO J. 4:1609–1614. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jeong HS, Jeong IC, Kim A, Kang SW, Kang
HS, Kim YJ, Lee SH and Park JS: Cloning of the large subunit of
replication protein A (RPA) from yeast Saccharomyces cerevisiae and
its DNA binding activity through redox potential. J Biochem Mol
Biol. 35:194–198. 2002.PubMed/NCBI
|
|
38
|
Unoki M, Okutsu J and Nakamura Y:
Identification of a novel human gene, ZFP91, involved in acute
myelogenous leukemia. Int J Oncol. 22:1217–1223. 2003.PubMed/NCBI
|
|
39
|
Li W, Zhang H, Min P, Zhu J, Xu D, Jiang
W, Ma Y, Qiu J, Xu W, Chen J, et al: Downregulated miRNA-1269a
variant (rs73239138) decreases the susceptibility to gastric cancer
via targeting ZNF70. Oncol Lett. 14:6345–6354. 2017.PubMed/NCBI
|
|
40
|
Westwick JK, Lee RJ, Lambert QT, Symons M,
Pestell RG, Der CJ and Whitehead IP: Transforming potential of Dbl
family proteins correlates with transcription from the cyclin D1
promoter but not with activation of Jun NH2-terminal kinase,
p38/Mpk2, serum response factor, or c-Jun. J Biol Chem.
273:16739–16747. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhu K, Debreceni B, Bi F and Zheng Y:
Oligomerization of DH domain is essential for Dbl-induced
transformation. Mol Cell Biol. 21:425–437. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Thompson HG, Harris JW and Brody JP:
Post-translationally modified S12, absent in transformed breast
epithelial cells, is not associated with the 26S proteasome and is
induced by proteasome inhibitor. Int J Cancer. 111:338–347. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kim JE, Yoo C, Lee DH, Kim SW, Lee JS and
Suh C: Serum albumin level is a significant prognostic factor
reflecting disease severity in symptomatic multiple myeloma. Ann
Hematol. 89:391–397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dimopoulos M, Gika D, Zervas K, Kyrtsonis
M, Symeonidis A, Anagnostopoulos A, Bourantas K, Matsouka C and
Pangalis G: The international staging system for multiple myeloma
is applicable in symptomatic Waldenstrom's macroglobulinemia. Leuk
Lymphoma. 45:1809–1813. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen JH, Hsu SN, Huang TC, Wu YY, Lin C,
Chang PY, Chen YC and Ho CL: Prognostic significance of initial
serum albumin and 24 h daily protein excretion before treatment in
multiple myeloma. PLoS One. 10:e01289052015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Allison AC: Structure and function of
plasma. Plenum Press; New York, NY: pp. 55–72. 1974
|
|
47
|
Langlois MR and Delanghe JR: Biological
and clinical significance of haptoglobin polymorphism in humans.
Clin Chem. 42:1589–1600. 1996.PubMed/NCBI
|
|
48
|
Sutton HE: The haptoglobins. Prog Med
Genet. 7:163–216. 1970.PubMed/NCBI
|
|
49
|
San Miguel J, Vicente V, Battle J,
Hernandez F and Lopez Borrasca A: Acute phase reactants and
clinical stages in multiple myeloma. Neoplasma. 28:333–338.
1981.PubMed/NCBI
|
